NCT01820546已完成不适用
Flow Cytometric Definition and Prognostic Effects of Multiple Myeloma Cancer Stem Cells
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 96
- 试验地点
- 1
- 主要终点
- Treatment Response
研究概览
简要总结
In multiple myeloma "cancer stem" cells can be defined and quantified with flow cytometry. More, these cells can be related to treatment response.
详细描述
The investigators' hypothesis is that, multiple myeloma plasma cells derivate from principal cells that is called "cancer or progenitor stem cell". In multiple myeloma to define immunophenotyping features of these "cancer stem cells" with flow cytometry and to show their prognostic value and check for any relationship between cancer stem cell quantification and chemotherapy response are main aims of this study.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •New Diagnosed or Relapsed Multiple Myeloma
- •Routine Bone Marrow Aspiration will be done
排除标准
- •Bone Marrow Aspiration is not Needed
结局指标
主要结局
Treatment Response
时间窗: 3 months
After 3 courses chemotherapy treatment response
次要结局
- Treatment Response(6 months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow CytometryMyelodysplastic SyndromesNCT06569095Peking University People's Hospital163
尚未招募
Unknown
sing tissue samples to help diagnose and predict the outcome of blood cancer using a machine that analyzes cell charecteristicsCTRI/2023/09/058112Dr Abhishek Tiwari
已完成
不适用
Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom AllergyAllergyNCT00805402University Hospital, Limoges75
招募中
不适用
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AMLAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaNCT06452732Peking University People's Hospital283
已完成
不适用
Role of flow cytometry in the assessment of restoration of hematopoiesis during standard Exjade® treatment in patients with low- intermediate I risk myelodysplastisc syndromes, a pilot studyn.a.10018849NL-OMON35738Vrije Universiteit Medisch Centrum20